FDA Approves Caplyta for Major Depressive Disorder in Adults
Approval is for adjunctive use with antidepressants
FDA Approves Darzalex Faspro for High-Risk Smoldering Multiple Myeloma
Compared with active monitoring, treatment reduced risk for disease progression by 51 percent
FDA Lifts Major Warnings on Hormone Replacement Therapy
Officials say the warnings were based on outdated 2002 study data involving older patients and old drug formulas
Icotrokinra Beneficial for Adults, Teens With Plaque Psoriasis
Icotronkinra results in significantly higher incidence of complete skin clearance at week 16 than placebo
AHA: GLP-1 Receptor Agonists Not Linked to Pancreatitis in Adults With High Triglycerides
Study also revealed no increased risk for major adverse cardiovascular events for patients on a GLP-1 RA versus those not on a GLP-1 RA
AHA: Targeted Vitamin D Supplementation Reduces Repeat MI Risk
No significant reduction in risk for major cardiovascular events seen in intention-to-treat analysis
ByHeart Infant Formula Recalled Amid Botulism Outbreak, Investigation Continues
Thirteen infants across 10 states have been hospitalized with botulism after consuming ByHeart baby formula
Nationwide Recall Alert: ADHD Drug May Not Dissolve Correctly
Affected patients should not stop taking their medication suddenly but should contact their doctor or pharmacy immediately
GI Safety Profile Similar for Dulaglutide, Semaglutide, Tirzepatide
No significant increase in hazard ratios seen for GI events for semaglutide versus dulaglutide, tirzepatide versus dulaglutide, tirzepatide versus semaglutide
Trump Announces Major Price Cut for Ozempic, Wegovy and Similar Drugs
The pricing applies to Medicare, Medicaid and a program launching later this year called TrumpRx
